MRM open to part­ner­ships af­ter lead can­di­date im­press­es in PhI­Ia ul­cer­a­tive col­i­tis tri­al

MRM Health’s mi­cro­bio­me con­sor­tium ther­a­py for ul­cer­a­tive col­i­tis has shown promise in a Phase IIa tri­al, trig­ger­ing plans for late-stage de­vel­op­ment and po­ten­tial part­ner­ships. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER